Trial Condition(s):

Constipation

Study to gather information on the acceptability of a new flavor system with increasing levels of 2, 4, 6 g or higher of Mannitol for PEG 3350 in subjects having infrequent bowel movements.

Bayer Identifier:

18160

ClinicalTrials.gov Identifier:

NCT04534465

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Study to gather information on the acceptability of a new flavor system with increasing levels of 2, 4, 6 g or higher of the sugar alcohol Mannitol for Polyethylene glycol (PEG) 3350 a drug stimulating bowel movement to pass stool in subjects having infrequent bowel movements. The taste of the various preparations will be measured by use of a rating scale.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
50
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Macrogol/MiraLAX (polyethylene glycol, BAY81-8430)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Merck Consumer Center

Memphis, United States, 38151

Status
Completed
 

Trial Design